American Heart Association

The latest news from the AHA Scientific Sessions, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention and more.
SPONSORED CONTENT
December 27, 2023
3 min read
Save

Menstrual cycle disorders tied to increasing CVD risk in young women, teens

PHILADELPHIA — Two common reproductive health conditions, dysmenorrhea and polycystic ovary syndrome, are associated with increasing CVD risk in women, according to research presented at the American Heart Association Scientific Sessions.

SPONSORED CONTENT
December 26, 2023
2 min read
Save

Lifestyle intervention improves daily steps but not functional capacity in HFrEF

PHILADELPHIA — In patients with HF with reduced ejection fraction, a lifestyle intervention improved daily steps by 25%, but that did not translate to improvement in functional capacity, according to the results of the WATCHFUL trial.

SPONSORED CONTENT
December 24, 2023
4 min watch
Save

VIDEO: Gina Lundberg, MD, FACC, discusses navigating illness of a close family member

PHILADELPHIA — In this Healio video exclusive, Gina Lundberg, MD, FACC, discusses the anxiety and distress a clinician might feel when a spouse, child or close family member is navigating a serious illness.

SPONSORED CONTENT
December 20, 2023
2 min read
Save

Empagliflozin may reduce ventricular arrhythmias in patients with type 2 diabetes, ICDs

PHILADELPHIA — In the EMPA-ICD trial, patients with type 2 diabetes and an implantable cardioverter defibrillator had fewer ventricular arrhythmias at 24 weeks when assigned empagliflozin compared with placebo.

SPONSORED CONTENT
December 19, 2023
4 min read
Save

Vigorous exercise not linked to risk for death, arrhythmias in long QT syndrome

PHILADELPHIA — In people with congenital long QT syndrome, vigorous exercise did not raise risk for death or ventricular arrhythmias compared with nonvigorous exercise, according to the results of the LIVE-LQTS study.

SPONSORED CONTENT
December 07, 2023
3 min read
Save

Liraglutide plus risk factor modification improves freedom from AF after ablation: LEAF

PHILADELPHIA — Adults with obesity and atrial fibrillation treated with liraglutide plus risk factor modification had improved outcomes after catheter ablation compared with those prescribed risk factor modification alone.

SPONSORED CONTENT
December 06, 2023
3 min read
Save

Incidence of sudden cardiac death among college athletes declined in recent years

PHILADELPHIA — The incidence of sudden cardiac death among National Collegiate Athletic Association athletes decreased over the past 2 decades, researchers reported at the American Heart Association Scientific Sessions.

SPONSORED CONTENT
December 03, 2023
4 min watch
Save

VIDEO: Dhruv Kazi, MD, MSc, MS, highlights importance of underutilized cardiac rehab

PHILADELPHIA — In this Healio video exclusive, Dhruv S. Kazi, MD, MSc, MS, discusses the importance of cardiac rehabilitation, noting that a comprehensive program is “more than just supervised exercise.”

SPONSORED CONTENT
December 02, 2023
5 min watch
Save

VIDEO: Michael C. Honigberg, MD, MPP, discusses bone marrow abnormality linked to CVD

PHILADELPHIA — In this Healio video exclusive, Michael C. Honigberg, MD, MPP, discusses the latest research on clonal hematopoiesis of indeterminate potential in blood cells, an emerging risk factor for CVD.

SPONSORED CONTENT
December 01, 2023
3 min read
Save

Etripamil reduces ventricular rate in patients with AF

PHILADELPHIA — Etripamil, a nasal spray, reduced ventricular rate in patients with atrial fibrillation and rapid ventricular rate, researchers reported at the American Heart Association Scientific Sessions.

American Heart Association Scientific Sessions

November 08, 2025 - November 10, 2025

New Orleans, Louisiana

American Heart Association Scientific Sessions

November 08, 2025 - November 10, 2025

New Orleans, Louisiana